The Goldilocks model for TCR-too much attraction might not be best for vaccine design
- PMID: 20856901
- PMCID: PMC2939021
- DOI: 10.1371/journal.pbio.1000482
The Goldilocks model for TCR-too much attraction might not be best for vaccine design
Abstract
Recent research on T cell-antigen interactions suggests that tighter binding is not always better at eliciting an effective immune response.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

Comment on
- PLoS Biol. 8:e1000481.
Similar articles
-
Recombinant adenovirus vaccine encoding a chimeric T-cell antigen receptor induces protective immunity against a T-cell lymphoma.Cancer Res. 2000 May 15;60(10):2689-95. Cancer Res. 2000. PMID: 10825142
-
Humoral immunoreaction induced by TCR DNA vaccine for beta chain of T cell lymphoma.Vaccine. 2004 May 7;22(15-16):2031-41. doi: 10.1016/j.vaccine.2003.05.003. Vaccine. 2004. PMID: 15121317
-
Identification of potential vaccine targets for COVID-19 by combining single-cell and bulk TCR sequencing.Clin Transl Med. 2021 May;11(5):e430. doi: 10.1002/ctm2.430. Clin Transl Med. 2021. PMID: 34047471 Free PMC article. No abstract available.
-
Optimizing vaccine design for cellular processing, MHC binding and TCR recognition.Tissue Antigens. 2002 Jun;59(6):443-51. doi: 10.1034/j.1399-0039.2002.590601.x. Tissue Antigens. 2002. PMID: 12445314 Review.
-
T-cell antigen receptors.Dermatol Clin. 1990 Oct;8(4):663-72. Dermatol Clin. 1990. PMID: 2249358 Review.
Cited by
-
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.J Immunother Cancer. 2019 Nov 5;7(1):284. doi: 10.1186/s40425-019-0773-z. J Immunother Cancer. 2019. PMID: 31690351 Free PMC article.
-
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells.Nat Commun. 2024 Dec 3;15(1):10520. doi: 10.1038/s41467-024-53911-0. Nat Commun. 2024. PMID: 39627205 Free PMC article.
-
Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment.Cancers (Basel). 2022 Aug 29;14(17):4192. doi: 10.3390/cancers14174192. Cancers (Basel). 2022. PMID: 36077730 Free PMC article. Review.
-
Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.Sci Signal. 2011 Jun 7;4(176):ra39. doi: 10.1126/scisignal.2001430. Sci Signal. 2011. PMID: 21653229 Free PMC article.
-
Enhanced T cell receptor specificity through framework engineering.Front Immunol. 2024 Mar 12;15:1345368. doi: 10.3389/fimmu.2024.1345368. eCollection 2024. Front Immunol. 2024. PMID: 38545094 Free PMC article.
References
-
- Bjorkman P. J, Strominger J. L, Wiley D. C. Crystallization and X-ray diffraction studies on the histocompatibility antigens HLA-A2 and HLA-A28 from human cell membranes. J Mol Biol. 1985;186:205–210. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical